Mammalian transforming growth factor-??s: Smad signaling and physio-pathological roles, The International Journal of Biochemistry & Cell Biology, vol.36, issue.7, pp.1161-1165, 2004. ,
DOI : 10.1016/S1357-2725(03)00255-3
Smad transcription factors, Genes & Development, vol.19, issue.23, pp.2783-2810, 2005. ,
DOI : 10.1101/gad.1350705
URL : http://genesdev.cshlp.org/cgi/content/short/19/23/2783
Abrogation of TGF-?? signaling enhances chemokine production and correlates with prognosis in human breast cancer, Journal of Clinical Investigation, vol.119, issue.6, pp.1571-1582, 2009. ,
DOI : 10.1172/JCI37480DS1
TGF-beta signaling in cancer?a double-edged sword, Trends Cell Biol, vol.11, pp.44-51, 2001. ,
TGF-beta signaling in tumor suppression and cancer progression, Nature Genetics, vol.29, issue.2, pp.117-129, 2001. ,
DOI : 10.1038/ng1001-117
Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer, Biochim Biophys Acta, vol.1775, pp.21-62, 2007. ,
Structure and activities of the ski oncogene, Semin Cancer Biol, vol.1, pp.383-387, 1990. ,
The ski oncogene induces muscle differentiation in quail embryo cells, Cell, vol.59, issue.2, pp.293-303, 1989. ,
DOI : 10.1016/0092-8674(89)90291-2
Ski/Sno and TGF-?? signaling, Cytokine & Growth Factor Reviews, vol.12, issue.1, pp.1-8, 2001. ,
DOI : 10.1016/S1359-6101(00)00031-9
Ski and SnoN: negative regulators of TGF-?? signaling, Current Opinion in Genetics & Development, vol.14, issue.1, pp.65-70, 2004. ,
DOI : 10.1016/j.gde.2003.11.003
SnoN in TGF-β Signaling and Cancer Biology, Current Molecular Medicine, vol.8, issue.4, pp.319-328, 2008. ,
DOI : 10.2174/156652408784533797
Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor, Proceedings of the National Academy of Sciences, vol.97, issue.11, pp.5924-5929, 2000. ,
DOI : 10.1073/pnas.090097797
Interaction of the Ski Oncoprotein with Smad3 Regulates TGF-?? Signaling, Molecular Cell, vol.4, issue.4, pp.499-509, 1999. ,
DOI : 10.1016/S1097-2765(00)80201-4
The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling, Genes & Development, vol.13, issue.17, pp.2196-2206, 1999. ,
DOI : 10.1101/gad.13.17.2196
Cytoplasmic localization of the oncogenic protein ski in human cutaneous melanomas in vivo: functional implications for transforming growth factor Beta signaling, Cancer Res, vol.61, pp.8074-8078, 2001. ,
Cytoplasmic SnoN in normal tissues and nonmalignant cells antagonizes TGF-?? signaling by sequestration of the Smad proteins, Proceedings of the National Academy of Sciences, vol.102, issue.35, pp.12437-12442, 2005. ,
DOI : 10.1073/pnas.0504107102
URL : https://hal.archives-ouvertes.fr/inserm-00194408
The Transforming Activity of Ski and SnoN Is Dependent on Their Ability to Repress the Activity of Smad Proteins, Journal of Biological Chemistry, vol.278, issue.33, pp.30540-30547, 2003. ,
DOI : 10.1074/jbc.M304016200
SnoN Is a Cell Type-specific Mediator of Transforming Growth Factor-?? Responses, Journal of Biological Chemistry, vol.280, issue.13, pp.13037-13046, 2005. ,
DOI : 10.1074/jbc.M409367200
ING2 as a Novel Mediator of Transforming Growth Factor-??-dependent Responses in Epithelial Cells, Journal of Biological Chemistry, vol.283, issue.19, pp.13269-13279, 2008. ,
DOI : 10.1074/jbc.M708834200
Transforming Growth Factor-?? Suppresses the Ability of Ski to Inhibit Tumor Metastasis by Inducing Its Degradation, Cancer Research, vol.68, issue.9, pp.3277-3285, 2008. ,
DOI : 10.1158/0008-5472.CAN-07-6793
SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling, Proceedings of the National Academy of Sciences, vol.96, issue.22, pp.12442-12447, 1999. ,
DOI : 10.1073/pnas.96.22.12442
Arkadia Activates Smad3/Smad4-Dependent Transcription by Triggering Signal-Induced SnoN Degradation, Molecular and Cellular Biology, vol.27, issue.17, pp.6068-6083, 2007. ,
DOI : 10.1128/MCB.00664-07
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1952153
Arkadia Induces Degradation of SnoN and c-Ski to Enhance Transforming Growth Factor-beta Signaling, Journal of Biological Chemistry, vol.282, issue.28, pp.20492-20501, 2007. ,
DOI : 10.1074/jbc.M701294200
Arkadia Enhances Nodal/TGF-?? Signaling by Coupling Phospho-Smad2/3 Activity and Turnover, PLoS Biology, vol.296, issue.3, p.67, 2007. ,
DOI : 10.1371/journal.pbio.0050067.sg006
Arkadia amplifies TGF-?? superfamily signalling through degradation of Smad7, The EMBO Journal, vol.8, issue.24, pp.6458-6470, 2003. ,
DOI : 10.1038/23293
Arkadia enhances nodalrelated signalling to induce mesendoderm, Nature, vol.410, issue.6830, pp.830-834, 2001. ,
DOI : 10.1038/35071103
Regulation of TGF-?? family signaling by E3 ubiquitin ligases, Cancer Science, vol.8, issue.Suppl 1, pp.2107-2112, 2008. ,
DOI : 10.1111/j.1349-7006.2008.00925.x
Increased susceptibility to tumorigenesis of ski-deficient heterozygous mice, Oncogene, vol.20, issue.56, pp.8100-8108, 2001. ,
DOI : 10.1038/sj.onc.1204987
Loss of the SKI proto-oncogene in individuals affected with 1p36 deletion syndrome is predicted by strain-dependent defects in Ski???/??? mice, Nature Genetics, vol.30, issue.1, pp.106-109, 2002. ,
DOI : 10.1038/ng770
Elevated plasma levels of transforming growth factor (TGF)-??1 and TGF-??2 in patients with disseminated malignant melanoma, British Journal of Cancer, vol.77, issue.9, pp.1492-1494, 1998. ,
DOI : 10.1038/bjc.1998.245
Expression of transforming growth factor-beta 2 in malignant melanoma correlates with the depth of tumor invasion. Implications for tumor progression, Am J Pathol, vol.145, pp.97-104, 1994. ,
Transforming growth factor-?? in cutaneous melanoma, Pigment Cell & Melanoma Research, vol.103, issue.1-2, pp.123-132, 2008. ,
DOI : 10.1111/j.1755-148X.2008.00450.x
Independent regulation of growth and SMAD-mediated transcription by transforming growth factor beta in human melanoma cells, Cancer Res, vol.59, pp.547-550, 1999. ,
Stable Overexpression of Smad7 in Human Melanoma Cells Impairs Bone Metastasis, Cancer Research, vol.67, issue.5, pp.2317-2324, 2007. ,
DOI : 10.1158/0008-5472.CAN-06-3950
URL : https://hal.archives-ouvertes.fr/inserm-00147397
Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo, Oncogene, vol.59, issue.51, pp.7624-7629, 2005. ,
DOI : 10.1074/jbc.M309798200
URL : https://hal.archives-ouvertes.fr/inserm-00147458
TGF-??-RI Kinase Inhibitor SD-208 Reduces the Development and Progression of Melanoma Bone Metastases, Cancer Research, vol.71, issue.1, pp.175-184, 2011. ,
DOI : 10.1158/0008-5472.CAN-10-2651
SKI knockdown inhibits human melanoma tumor growth in vivo, Pigment Cell & Melanoma Research, vol.27, issue.6, pp.761-772, 2009. ,
DOI : 10.1111/j.1755-148X.2009.00603.x
SKI pathways inducing progression of human melanoma, Cancer and Metastasis Reviews, vol.425, issue.2, pp.265-272, 2005. ,
DOI : 10.1007/s10555-005-1576-x
Characterization of Sno expression in malignant melanoma, International Journal of Oncology, vol.26, pp.1411-1417, 2005. ,
DOI : 10.3892/ijo.26.5.1411
GLI2-Mediated Melanoma Invasion and Metastasis, JNCI Journal of the National Cancer Institute, vol.102, issue.15, pp.1148-1159, 2010. ,
DOI : 10.1093/jnci/djq257
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914763
Parathyroid hormone-related protein (PTHrP)-(1-139) isoform is efficiently secreted in vitro and enhances breast cancer metastasis to bone in vivo, Bone, vol.30, issue.5, pp.670-676, 2002. ,
DOI : 10.1016/S8756-3282(02)00685-3
A multigenic program mediating breast cancer metastasis to bone, Cancer Cell, vol.3, issue.6, pp.537-549, 2003. ,
DOI : 10.1016/S1535-6108(03)00132-6
TGF-?? signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development, Journal of Clinical Investigation, vol.103, issue.2, pp.197-206, 1999. ,
DOI : 10.1172/JCI3523
JNK supports survival in melanoma cells by controlling cell cycle arrest and apoptosis, Pigment Cell & Melanoma Research, vol.331, issue.4, pp.429-438, 2008. ,
DOI : 10.1111/j.1755-148X.2008.00466.x
Clinical significance of the expression of c-Ski and SnoN, possible mediators in TGF-?? resistance, in primary cutaneous melanoma, Journal of Dermatological Science, vol.53, issue.1, pp.26-33, 2009. ,
DOI : 10.1016/j.jdermsci.2008.07.010
Transforming Growth Factor-?? Activation Promotes Genetic Context-Dependent Invasion of Immortalized Melanocytes, Cancer Research, vol.68, issue.11, pp.4248-4257, 2008. ,
DOI : 10.1158/0008-5472.CAN-07-5671
TGF-??-mediated activation of RhoA signalling is required for efficient V12HaRas and V600EBRAF transformation, Oncogene, vol.270, issue.7, pp.983-993, 2009. ,
DOI : 10.1038/onc.2008.449
Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-??: implications for carcinogenesis, Oncogene, vol.270, issue.37, pp.5742-5750, 2005. ,
DOI : 10.1016/S0378-1119(00)00162-1
URL : https://hal.archives-ouvertes.fr/inserm-00147399
Expression of angiogenic and immunosuppressive factors by uveal melanoma cell lines, Melanoma Research, vol.9, issue.5, pp.445-450, 1999. ,
DOI : 10.1097/00008390-199910000-00003
Selective induction of interleukin-8 expression in metastatic melanoma cells by transforming growth factor-??1, Cytokine, vol.31, issue.3, pp.241-249, 2005. ,
DOI : 10.1016/j.cyto.2005.03.008
Effects of Various Synthetic Retinoids on Proliferation and Immunophenotype of Human Melanoma Cells In Vitro, Recent Results Cancer Res, vol.139, pp.183-193, 1995. ,
DOI : 10.1007/978-3-642-78771-3_13
Autocrine TGF-?-regulated expression of adhesion receptors and integrin-linked kinase in HT-144 melanoma cells correlates with their metastatic phenotype, International Journal of Cancer, vol.273, issue.2, pp.255-262, 1999. ,
DOI : 10.1002/(SICI)1097-0215(19991008)83:2<255::AID-IJC18>3.0.CO;2-X
Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature, Pigment Cell Research, vol.11, issue.4, pp.290-302, 2006. ,
DOI : 10.1016/S0960-9822(01)00360-8
Role of interleukin 10 and transforming growth factor beta1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice, Clin Cancer Res, vol.5, pp.711-720, 1999. ,
Regulation of Invasion of Epithelial Ovarian Cancer by Transforming Growth Factor-??, Gynecologic Oncology, vol.80, issue.2, pp.245-253, 2001. ,
DOI : 10.1006/gyno.2000.6042
TGF?? signaling is necessary for carcinoma cell invasiveness and metastasis, Current Biology, vol.8, issue.23, pp.1243-1252, 1998. ,
DOI : 10.1016/S0960-9822(07)00533-7
URL : http://doi.org/10.1016/s0960-9822(07)00533-7
Suppression of tumor metastasis by blockade of transforming growth factor beta signaling in bone marrow cells through a retroviral-mediated gene therapy in mice, Cancer Res, vol.62, pp.7135-7138, 2002. ,
Blockade of TGF-?? inhibits mammary tumor cell viability, migration, and metastases, Journal of Clinical Investigation, vol.109, issue.12, pp.1551-1559, 2002. ,
DOI : 10.1172/JCI0215234
SD-208, a Novel Transforming Growth Factor ?? Receptor I Kinase Inhibitor, Inhibits Growth and Invasiveness and Enhances Immunogenicity of Murine and Human Glioma Cells In vitro and In vivo, Cancer Research, vol.64, issue.21, pp.7954-7961, 2004. ,
DOI : 10.1158/0008-5472.CAN-04-1013
Lifetime exposure to a soluble TGF-?? antagonist protects mice against metastasis without adverse side effects, Journal of Clinical Investigation, vol.109, issue.12, pp.1607-1615, 2002. ,
DOI : 10.1172/JCI200215333
Development of TGF-?? signalling inhibitors for cancer therapy, Nature Reviews Drug Discovery, vol.9, issue.12, pp.1011-1022, 2004. ,
DOI : 10.1038/35094059
Transforming the TGFbeta pathway: convergence of distinct lead generation strategies on a novel kinase pharmacophore for TbetaRI (ALK5), Curr Opin Drug Discov Devel, vol.7, pp.437-445, 2004. ,
Large-and small-molecule inhibitors of transforming growth factor-beta signaling, Curr Opin Investig Drugs, vol.7, pp.513-521, 2006. ,
Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness, Nature Medicine, vol.155, issue.8, pp.925-932, 2006. ,
DOI : 10.1038/nm1448
TGF-beta repressors SnoN and Ski are implicated in human colorectal carcinogenesis, Cell Oncol, vol.31, pp.41-51, 2009. ,
SKI is critical for repressing the growth inhibitory function of TGF- in human melanoma, Pigment Cell & Melanoma Research, vol.278, issue.4, pp.494-495, 2008. ,
DOI : 10.1111/j.1755-148X.2008.00476.x
Constitutive Expression of Multiple Growth Factor Genes by Melanoma Cells but Not Normal Melanocytes, Journal of Investigative Dermatology, vol.97, issue.1, pp.20-26, 1991. ,
DOI : 10.1111/1523-1747.ep12477822
Involvement of cadherins 7 and 20 in mouse embryogenesis and melanocyte transformation, Oncogene, vol.23, issue.40, pp.6726-6735, 2004. ,
DOI : 10.1038/sj.onc.1207675
Responsiveness of normal, dysplastic melanocytes and melanoma cells from different lesional stages of disease progression to the growth inhibitory effects of TGFbeta, Mol Cell Diff, vol.1, pp.21-40, 1993. ,
Direct binding of Smad3 and Smad4 to critical TGFbeta -inducible elements in the promoter of human plasminogen activator inhibitor-type 1gene, The EMBO Journal, vol.17, issue.11, pp.3091-3100, 1998. ,
DOI : 10.1093/emboj/17.11.3091
WAF1, a potential mediator of p53 tumor suppression, Cell, vol.75, issue.4, pp.817-825, 1993. ,
DOI : 10.1016/0092-8674(93)90500-P
Disruption of Basal JNK Activity Differentially Affects Key Fibroblast Functions Important for Wound Healing, Journal of Biological Chemistry, vol.278, issue.27, pp.24624-24628, 2003. ,
DOI : 10.1074/jbc.M301942200
URL : https://hal.archives-ouvertes.fr/inserm-00147462
Cell-Type-Specific Activation of PAK2 by Transforming Growth Factor ?? Independent of Smad2 and Smad3, Molecular and Cellular Biology, vol.23, issue.23, pp.8878-8889, 2003. ,
DOI : 10.1128/MCB.23.23.8878-8889.2003